Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release

BACKGROUND AND PURPOSE: Glioma is one of the most aggressive primary brain tumors and is incurable. Surgical resection, radiation, and chemotherapies have been the standard treatments for brain tumors, however, they damage healthy tissue. Therefore, there is a need for safe anticancer drug delivery...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahein, Samar A, Aboul-Enein, Ahmed M, Higazy, Iman M, Abou-Elella, Faten, Lojkowski, Witold, Ahmed, Esam R, Mousa, Shaker A, AbouAitah, Khaled
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650459/
https://www.ncbi.nlm.nih.gov/pubmed/31410001
http://dx.doi.org/10.2147/IJN.S206899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650459/
https://www.ncbi.nlm.nih.gov/pubmed/31410001
http://dx.doi.org/10.2147/IJN.S206899

Ejemplares similares